{
  "data": {
    "id": "stat_BQ5XYTBPZ1H5M9TNFTWWVTV9EP",
    "url": "https://statorigin.org/stat/stat_BQ5XYTBPZ1H5M9TNFTWWVTV9EP",
    "indicator": {
      "slug": "innovative-medicines-spending-target-share-of-gdp",
      "name": "Innovative medicines spending target share of GDP",
      "definition": "Targeted government expenditure on innovative medicines expressed as a percentage of gross domestic product."
    },
    "industry": [
      {
        "slug": "pharmaceuticals",
        "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
        "isic": "C21",
        "is_primary": true
      }
    ],
    "region": {
      "code": "GB",
      "name": "United Kingdom",
      "type": "country"
    },
    "period": {
      "start": "2026-09-08",
      "end": "2026-09-08",
      "type": "point"
    },
    "value": 0.6,
    "value_text": "0.6%",
    "unit": "percent",
    "currency": null,
    "scale": "1",
    "value_type": "forecast",
    "source": {
      "org": "Association of the British Pharmaceutical Industry",
      "org_short_name": "ABPI",
      "org_url": "https://www.abpi.org.uk",
      "org_tier": 2,
      "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
      "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
      "document_type": "press_release",
      "locator": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
      "quote": "These investments have been made possible through collaboration between industry and government, alongside a combination of short- and long-term policy commitments, including an increase to the baseline cost-benefit threshold used by NICE and a commitment to increase UK investment in innovative medicines to 0.6% of GDP.",
      "published_date": null,
      "accessed_at": "2026-09-17",
      "license": "see-source",
      "url_status": "ok"
    },
    "verification": "verified",
    "verified_by": "seed:auto-extract-v1",
    "verified_at": "2026-09-17T07:16:01.811Z",
    "confidence": 0.9,
    "is_secondhand": false,
    "supersedes": null,
    "superseded_by": null,
    "is_current": true,
    "citation": {
      "apa": "Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_BQ5XYTBPZ1H5M9TNFTWWVTV9EP",
      "bibtex": "@misc{abpi2026innovativevtv9ep,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_BQ5XYTBPZ1H5M9TNFTWWVTV9EP},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
    },
    "updated_at": "2026-09-17T07:16:01.811Z",
    "contested_by": [],
    "related": []
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}